ARS Pharmaceuticals Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

14.20

0.23 (1.65%)

At close: May 01, 2025, 3:59 PM

ARS Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	50.82M	70.97M	210.52M	60.06M	24.52M	9.98M	20.16M
Short-Term Investments	263.2M	157.39M	63.86M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	64.78M	350K	550K	750K
Other Long-Term Assets	8.42M	21K	2.96M	-64.76M	-348K	n/a	n/a
Receivables	9.16M	795K	n/a	1K	384K	n/a	n/a
Inventory	5.21M	n/a	-1.01M	-6.78M	-2.61M	n/a	n/a
Other Current Assets	1.23M	163K	n/a	n/a	n/a	552K	618K
Total Current Assets	334.3M	231.73M	277.7M	60.73M	26.38M	10.53M	20.78M
Property-Plant & Equipment	1.07M	824K	774K	693K	23K	4.57M	6.02M
Goodwill & Intangibles	7.37M	617K	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	16.86M	1.46M	3.73M	716K	25K	5.12M	6.77M
Total Assets	351.15M	233.19M	281.44M	61.45M	26.41M	15.65M	27.55M
Account Payables	9.87M	759K	1.66M	1.79M	1.22M	3.52M	775K
Deferred Revenue	557K	n/a	283K	1.46M	3.52M	n/a	n/a
Short-Term Debt	42K	n/a	230K	3.48M	2.56M	12.3M	3.53M
Other Current Liabilities	2.29M	1.08M	2.6M	660K	n/a	2.11M	841K
Total Current Liabilities	23.44M	2.39M	5.44M	8.19M	8.21M	17.93M	5.14M
Long-Term Debt	n/a	n/a	n/a	4.93M	7.46M	n/a	n/a
Other Long-Term Liabilities	70.92M	n/a	n/a	76.12M	27K	n/a	-1
Total Long-Term Liabilities	70.92M	37K	3.1M	84.53M	32.25M	3.32M	4.21M
Total Liabilities	94.36M	2.43M	8.55M	92.72M	40.46M	21.25M	9.35M
Total Debt	42K	274K	481K	9.03M	10.02M	15.62M	7.73M
Common Stock	10K	10K	9K	257K	223K	n/a	n/a
Retained Earnings	-123.31M	-131.3M	-76.94M	-42.26M	-22.01M	-63.79M	-39.82M
Comprehensive Income	n/a	49K	407K	-326K	-21.23M	n/a	n/a
Shareholders Equity	256.8M	230.76M	272.89M	-31.27M	-14.05M	-5.6M	18.2M
Total Investments	263.2M	157.39M	63.86M	64.78M	350K	550K	750K